Peter Stebbins, Nurami Medical - Soft Tissue Repair Technologies | LSI Europe '22

The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs.
Speakers
Peter Stebbins
Executive Chair of the Board, Nurami Medical